drugset / Trial / NCT01931176

Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults

NCT01931176 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Dengue viruses can cause dengue fever and other more serious illnesses. The purpose of this study is to evaluate the safety and immune response to a dengue virus vaccine.

Timeline

Start
2013-06
Primary completion
2014-12
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject rDEN2Δ30-7169 Vaccine 1000 unknown Subcutaneous

Indications